Study title: MRL Clinical Study Report: An Open, Two-Period Crossover Study to Determine the Relative Bioavailability of Lisinopril Suspension 20 mg and Marketed PRINIVILâ„¢ 20-mg Tablets (Protocol 037).
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Cardiovascular Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: LISINOPRIL | |||||
ATC code: C 09 AA 03 | |||||
Document link: | |||||
Document date: | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | Y | Y |